Consolidated Balance Sheets - USD ($)		Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents		$ 125,044,092	$ 103,022,932
Inventories		1,494,891	3,090,923
Finance lease receivables, current – related parties		5,992,585	6,143,564
Customer loans receivable, current		10,382,537	8,484,753
Prepaid expenses and other current assets		11,276,802	10,050,005
Total current assets		184,451,020	165,905,926
Non-current assets:
Property and equipment, net		8,771,902	13,582,017
Intangible assets, net		1,590,052	19,739,276
Long-term investments, net		3,049,972	849,434
Goodwill, net		4,613,784	3,590,791
Finance lease receivables, non-current – related parties		8,397,582	3,420,489
Operating lease right-of-use assets		5,267,056	5,919,937
Deferred tax assets		9,798,071
Customer loans receivable, non-current		5,023,551	6,444,025
Long-term prepayments		1,745,801	4,099,763
Long-term investments in MCs – related parties		17,820,910	19,811,555
Other assets		15,553,453	15,442,058
Total non-current assets		81,632,134	92,899,345
Total assets		266,083,154	258,805,271
Current liabilities:
Current portion of long-term loans		96,824	156,217
Notes payable, current – related parties		26,255	3,369,203
Income tax payable		18,705,851	8,782,930
Operating lease liabilities, current		4,341,522	3,885,812
Accrued liabilities and other current liabilities		8,103,194	21,009,009
Total current liabilities		61,191,890	92,451,270
Non-current liabilities:
Long-term loans		6,502,682	1,062,722
Notes payable, non-current – related parties		5,334	11,948,219
Deferred tax liabilities		926,023	6,013,565
Operating lease liabilities, non-current		1,241,526	2,444,316
Other liabilities		1,193,541	1,074,930
Total non-current liabilities		9,869,106	22,543,752
Total liabilities		71,060,996	114,995,022
Stockholders’ equity:
Preferred stock ($0.0001 par value, 20,000,000 shares authorized; no shares issued and outstanding as of December 31, 2024 and 2023)	[1]
Common stock ($0.0001 par value, 400,000,000 shares authorized, 103,020,816 and 94,192,433 shares issued, 102,750,816 and 94,192,433 shares outstanding as of December 31, 2024 and 2023, respectively)	[1]	10,302	9,419
Additional paid-in capital	[1]	62,513,923	36,879,281
Treasury stock (at cost, 270,000 and nil shares as of December 31, 2024 and 2023, respectively)		(2,700,000)
Retained earnings		189,463,007	142,848,732
Accumulated other comprehensive loss		(54,178,075)	(37,578,255)
Total SBC Medical Group Holdings Incorporated stockholders’ equity		195,109,157	142,159,177
Non-controlling interests		(86,999)	1,651,072
Total stockholders’ equity		195,022,158	143,810,249
Total liabilities and stockholders’ equity		266,083,154	258,805,271
Nonrelated Party [Member]
Current assets:
Accounts receivable		1,413,433	1,437,077
Current liabilities:
Accounts payable		13,875,179	26,531,944
Advances from customers		820,898	2,074,457
Related Party [Member]
Current assets:
Accounts receivable		28,846,680	33,676,672
Current liabilities:
Accounts payable		659,044
Advances from customers		11,739,533	23,058,175
Due to related party		$ 2,823,590	$ 3,583,523

[1] Retrospectively restated for effect of reverse recapitalization on September 17, 2024.